CSBR vs USB · P/E 16, rev $56.9M vs P/E 12, rev $28.66B
Champions Oncology Inc (CSBR) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the CSBR and USB stock pages for the full models.
Not investment advice.